Antigen-specific targeting of immune system offers treatment approach to improve efficacy of biologic drugs
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company developing targeted antigen-specific immune therapies for rare and serious diseases, announced today that Nature Nanotechnology has published an article ...